Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 2,062.50
+27.90 (1.37%)
Nov 12, 2026, 3:30 PM IST
Wockhardt Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 38,400 | 34,620 | 30,420 | 28,300 | 26,570 | 32,300 |
Revenue Growth | 27.70% | 13.81% | 7.49% | 6.51% | -17.74% | 19.28% |
Gross Profit Gross Profit Growth | 24,590 | 22,450 | 18,330 | 15,980 | 14,850 | 18,810 |
Operating Income Operating Income Growth | 5,820 | 4,920 | 2,100 | -210 | -1,430 | 510 |
Net Income Net Income Growth | 4,100 | 2,130 | -470 | -4,630 | -5,590 | -2,440 |
Earnings Per Share EPS Growth | 25.55 | 13.10 | -3.02 | -32.10 | -38.80 | -20.24 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 7,400 | 6,710 | 6,030 | 6,090 | 6,610 |
United States of America United States of America Growth | 10 | 880 | 1,470 | 3,030 | 3,420 |
Europe Europe Growth | 16,740 | 15,430 | 14,160 | 11,840 | 16,150 |
Rest of the World Rest of the World Growth | 9,580 | 7,100 | 6,320 | 5,550 | 6,120 |
Total Total Growth | 33,730 | 30,120 | 27,980 | 26,510 | 32,300 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 7,130 | 6,800 | 5,880 | 5,230 | 1,160 | 3,820 |
Total Debt Total Debt Growth | 22,380 | 22,330 | 20,210 | 23,560 | 21,840 | 21,980 |
Net Cash (Debt) Net Cash Growth | -15,250 | -15,530 | -14,330 | -18,330 | -20,680 | -18,160 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -95.00 | -95.48 | -91.33 | -127.07 | -143.55 | -150.63 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 4,380 | 3,900 | -220 | 2,190 | 1,530 | 4,130 |
Capital Expenditures CapEx Growth | -1,490 | -1,360 | -940 | -590 | -420 | -1,180 |
Free Cash Flow Free Cash Flow Growth | 2,890 | 2,540 | -1,160 | 1,600 | 1,110 | 2,950 |
Free Cash Flow Growth | 1421.05% | - | - | 44.14% | -62.37% | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 64.04% | 64.85% | 60.26% | 56.47% | 55.89% | 58.24% |
Operating Margin | 15.16% | 14.21% | 6.90% | -0.74% | -5.38% | 1.58% |
Pretax Margin | 11.59% | 6.87% | -0.53% | -14.84% | -23.49% | -12.72% |
Profit Margin | 10.68% | 6.15% | -1.54% | -16.36% | -21.04% | -7.55% |
FCF Margin | 7.53% | 7.34% | -3.81% | 5.65% | 4.18% | 9.13% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 80.74 | 89.69 | - | - | - | - |
Forward PE | - | 38.49 | 38.49 | 38.49 | 38.49 | 38.49 |
P/FCF Ratio | 115.97 | 75.21 | - | 56.15 | 19.98 | 12.87 |
PS Ratio | 8.73 | 5.52 | 7.61 | 3.18 | 0.84 | 1.18 |